0001144204-15-066014.txt : 20151116 0001144204-15-066014.hdr.sgml : 20151116 20151116161509 ACCESSION NUMBER: 0001144204-15-066014 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151112 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALLIED HEALTHCARE PRODUCTS INC CENTRAL INDEX KEY: 0000874710 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 231370721 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19266 FILM NUMBER: 151234634 BUSINESS ADDRESS: STREET 1: 1720 SUBLETTE AVE CITY: ST LOUIS STATE: MO ZIP: 63110 BUSINESS PHONE: 3147712400 MAIL ADDRESS: STREET 1: 1720 SUBLETTE AVENUE CITY: ST LOUIS STATE: MO ZIP: 63110 8-K 1 v424646_8k.htm FORM 8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) 
November 12, 2015

 

ALLIED HEALTHCARE PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware  0-19266  25-1370721 
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)

 

1720 Sublette Avenue, St. Louis, Missouri 
(Address of principal executive offices)		 63110
(Zip Code)

 

Registrant’s telephone number, including area code 
(314) 771-2400 
 
Not applicable 
(Former name or former address, if changed since last report) 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

ITEM 5.07. Submission of Matters to a Vote of Security Holders.

 

The annual meeting of the stockholders of Allied Healthcare Products, Inc. (the “Company”) was held on November 12, 2015. Proxies were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934. There was no solicitation in opposition to management’s nominees for Directors. The voting results are noted below.

 

ELECTION OF DIRECTORS

 

All nominees for Directors were elected with the following votes cast:

 

   For  Withheld  Broker Non-Votes
Judith T. Graves  5,885,178         4,064  1,047,012
Joseph E. Root  5,886,878         2,364  1,047,012
William A. Peck  5,860,116       29,126  1,047,012
Earl R. Refsland  5,886,782         2,460  1,047,012
John D. Weil  5,838,416       50,826  1,047,012

 

Agenda Item 2, concerning the ratification of the appointment of RubinBrown LLP as the Company’s independent registered public accounting firm for fiscal 2016 was approved by the stockholders with the following votes cast:

 

For  Against  Abstain  Broker Non-Votes
6,893,810  37,760  4,864  0

 

Agenda Item 3, an advisory (non-binding) vote to approve our executive compensation was approved by the stockholders with the following votes cast:

 

For  Against  Abstain  Broker Non-Votes
5,873,215  10,940  5,087  1,047,012

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ALLIED HEALTHCARE PRODUCTS, INC.
     
     
Date:  November 16, 2015 By: /s/  Daniel C. Dunn
    Daniel C. Dunn
    Chief Financial Officer